• Users Online: 1244
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 6  |  Issue : 2  |  Page : 88-96

Hidradenitis suppurativa: A review of available immunotherapeutic agents and advancement in treatment

1 University of Alabama at Birmingham School of Medicine, Birmingham, USA
2 Department of Dermatology, School of Medicine, University of Alabama at Birmingham, AL, USA

Correspondence Address:
Nabiha Yusuf
1670, University Boulevard, VH 566A, Birmingham, Alabama
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/cdr.cdr_53_21

Rights and Permissions

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that poses a significant diagnostic, as well as therapeutic, challenge for clinicians. The purpose of this review is to explore current treatment guidelines, as well as the newer, investigative immunotherapies, used in the management of HS. Through a detailed, albeit nonexhaustive, literature review, the most-recently published management guidelines and clinical trials concerning HS therapy were identified and their implication in current and future disease management was explored. An understanding of available treatment options, and what lies on the horizon, is important as researchers and clinicians work toward better understanding this unique disease.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded92    
    Comments [Add]    

Recommend this journal